The article discusses the potential of ChatGPT to enhance research in cosmetic plastic surgery. It highlights how AI can assist in various aspects, such as literature reviews, data analysis, and generating patient education materials.
The study analyzes public interest in the off-label use of glucagon-like peptide 1 (GLP-1) agonists, particularly Ozempic, for cosmetic weight loss through Google Trends data.